TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $12,283,000 | +7.2% | 79,478 | -0.9% | 0.85% | +14.2% |
Q3 2015 | $11,463,000 | -9.0% | 80,220 | -8.5% | 0.74% | +10.5% |
Q2 2015 | $12,600,000 | -27.6% | 87,686 | -28.9% | 0.67% | -15.8% |
Q1 2015 | $17,392,000 | +29.8% | 123,324 | +36.4% | 0.80% | +29.7% |
Q4 2014 | $13,395,000 | – | 90,393 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
Geduld E E | 8,000 | $1,122,000 | 0.70% |
Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |